Clinical Trials Logo

Specific Disorders of Sleep clinical trials

View clinical trials related to Specific Disorders of Sleep.

Filter by:
  • None
  • Page 1

NCT ID: NCT01348607 Terminated - Fatigue Clinical Trials

Methylphenidate HCl or Modafinil in Treating Young Patients With Excessive Daytime Sleepiness After Cancer Therapy

Start date: July 2010
Phase: Phase 2
Study type: Interventional

RATIONALE: Methylphenidate hydrochloride or modafinil may help reduce daytime sleepiness and improve the quality of life of patients with excessive daytime sleepiness after cancer therapy. It is not yet known whether methylphenidate hydrochloride or modafinil are more effective than a placebo in reducing daytime sleepiness in these patients. PURPOSE: This randomized phase II trial is studying methylphenidate hydrochloride or modafinil to see how well they work compared with a placebo in treating young patients with excessive daytime sleepiness after cancer therapy.